Dr. David Steensma
Cancer Treatment
22+
Years of Experience
About Dr. David Steensma
Dr. David P. Steensma is a hematologist-oncologist for over 25 years who is an internationally recognized expert in MDS and myeloproliferative diseases as well as clonal hematopoiesis.
- Professional Background
- 25+ years of clinical practice and research
- Chief Medical Officer, Ajax Therapeutics (Cambridge, MA)
- Former Edward P. Evans Chair in MDS & Faculty Physician, Dana-Farber Cancer Institute / Harvard Medical School
- Former Global Head of Hematology, Novartis Institutes for Biomedical Research
- Former Faculty Mayo Clinic Division of Hematology
- Board Certified in Internal Medicine, Hematology and Medical Oncology (ABIM)
- Fellowship in Hematology & Medical Oncology at Mayo Clinic; Research Scholar at Weatherall Institute, University of Oxford
- Conditions: MDS, myelofibrosis, AML, bone marrow failure, clonal hematopoiesis
- Research
- Over 200 original peer-reviewed research papers published.
- FDA Oncology Drug Advisory Committee (ODAC) voting member
- Numerous editorial positions; multiple American Society of Hematology roles and consultant editor for Journal of Clinical Oncology.
- Lead clinical development of AJ1-11095; Type II JAK2 inhibitor for myelofibrosis
Dr. Steensma's comprehensive experience in blood malignancy research and drug development serves the patients who require the intersection between academic and translational medicine.
Good to know
Speciality
Performed by Dr. David Steensma
Cancer Treatment
Cancer treatment abroad gives patients an access to world-class oncology centers offering chemotherapy, immunotherapy, targeted therapy, radiation, and surgical oncology. Multidisciplinary tumor boards of oncologists, surgeons, and radiologists collaborate to design personalized treatment plans. Oncology care costs can be financially devastating in many countries. Advanced cancer treatments that cost $80,000 to $200,000 at home may be available for $15,000 to $50,000 abroad at JCI-accredited hospitals with equally qualified oncologists and the latest treatment technologies. International cancer centers provide comprehensive care including PET-CT imaging, genomic tumor profiling, and access to clinical trials not available locally. Dedicated oncology case managers guide patients through every step of their treatment journey. The oncologist's experience and the hospital's technology are the most important factors to consider to ensure authenticity. Always confirm your treating team includes board-certified oncologists and that the facility is accredited by a recognized international body. Adherence to your full treatment protocol, nutritional support, and psychological well-being during treatment all significantly influence outcomes.
CureMeAbroadIs Absolutely Free
Just discovery so you can choose what's right for you!
World's No. 1 Medical Discovery Platform
Dr. David Steensma
David Steensma has been practicing medicine since 2004, giving them over 21 years of clinical experience. They currently serve as Senior Physician and have built a focused career in hematologist-oncologist.
Dr. David Steensma
You can request a consultation with David Steensma through CureMeAbroad by submitting your details. Video consultations are available for international patients before travel through CureMeAbroad.
Dr. David Steensma
Cancer treatment costs with David Steensma vary by cancer type, stage, and treatment protocol. Patients frequently save 40-70% compared to equivalent care in the US or UK. CureMeAbroad can help obtain a cost estimate after your medical records and pathology reports are reviewed.
How many years of experience does David Steensma have?
Dr. David Steensma
David Steensma has been practicing medicine since 2004, giving them over 21 years of clinical experience. They currently serve as Senior Physician and have built a focused career in hematologist-oncologist.
Which You Wanted To See
Topic Related
